The potential of the CSCs population in ovarian cancer cells is defined by cell markers, including ALDH enzymatic activity and the stem cell marker CD133 [16,17], suggesting the potential role of ALDH+/CD133+ cells as the ovarian cancer cells of origin [18]. This evidence concerns the gene PROM1 and ovarian cancer.